is tirzepatide a glp-1 Effects of tirzepatide, dual GIP and receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Pharmacogenomics of Tirzepatide: Genomic Insights

Common GLP-1 drugs include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) These drugs improve insulin resistance , aid in weight loss , and now appear to reduce inflammation , offering benefits far beyond diabetes

GLP-1 receptor agonists have also been shown to cause weight loss in some individuals

Argument in favor: Others say that if Medicare covers the cost of these drugs, it could help more people afford these medications and improve health and quality of life for people who are overweight

Finally, tirzepatide was associated with significantly reduced occurrence of a composite kidney outcome comprising new-onset MA, 40% eGFR decline, end-stage renal disease and death due to kidney failure (HR 0.58, 95% CI 0.430.80) [49]

J., Escribano, A., Moyano, M

PMID: 36857477